These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29130480)

  • 21. The IgM anti-desmoglein 1 response distinguishes Brazilian pemphigus foliaceus (fogo selvagem) from other forms of pemphigus.
    Diaz LA; Prisayanh PS; Dasher DA; Li N; Evangelista F; Aoki V; Hans-Filho G; dos Santos V; Qaqish BF; Rivitti EA;
    J Invest Dermatol; 2008 Mar; 128(3):667-75. PubMed ID: 17960181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of commercially available ELISA assays as a tool for monitoring and managing pemphigus patients: a prospective study.
    Bracke S; Speeckaert R; Van Geel N; De Bacquer D; Lambert J
    Eur J Dermatol; 2013; 23(1):33-9. PubMed ID: 23302186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages.
    Kamiya K; Aoyama Y; Yamasaki O; Kamata A; Yamagami J; Iwatsuki K; Tokura Y
    Br J Dermatol; 2016 Jan; 174(1):113-9. PubMed ID: 26294113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.
    Harman KE; Seed PT; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2001 Apr; 144(4):775-80. PubMed ID: 11298536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E-cadherin is an additional immunological target for pemphigus autoantibodies.
    Evangelista F; Dasher DA; Diaz LA; Prisayanh PS; Li N
    J Invest Dermatol; 2008 Jul; 128(7):1710-8. PubMed ID: 18219275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of sensitivity and specificity of enzyme-linked immunosorbent assay (ELISA) for detecting antidesmoglein 1 and 3 in Thai patients with pemphigus vulgaris and foliaceus.
    Kulkollakarn S; Wattanakrai P; Vachiramon V; Chalidapongse P
    J Med Assoc Thai; 2008 Nov; 91(11):1663-8. PubMed ID: 19127786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of anti-desmoglein-3 antibodies in endemic regions of Fogo selvagem in Brazil.
    Hilario-Vargas J; Dasher DA; Li N; Aoki V; Hans-Filho G; dos Santos V; Qaqish BF; Rivitti EA; Diaz LA;
    J Invest Dermatol; 2006 Sep; 126(9):2044-8. PubMed ID: 16763546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies.
    Hacker MK; Janson M; Fairley JA; Lin MS
    Clin Immunol; 2002 Oct; 105(1):64-74. PubMed ID: 12483995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrence of Tunisian pemphigus foliaceus.
    Kallel Sellami M; Ben Ayed M; Mouquet H; Drouot L; Zitouni M; Mokni M; Cerruti M; Turki H; Fezza B; Mokhtar I; Ben Osman A; Zahaf A; Kamoun MR; Joly P; Masmoudi H; Makni S; Tron F; Gilbert D
    Clin Exp Immunol; 2004 Jul; 137(1):195-200. PubMed ID: 15196262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High anti–desmoglein 3 antibody ELISA index and negative indirect immunofluorescence result in a patient with pemphigus vulgaris in remission: evaluation of the antibody profile by newly developed methods.
    Nakahara T; Takagi A; Yamagami J; Kamiya K; Aoyama Y; Iwatsuki K; Ikeda S
    JAMA Dermatol; 2014 Dec; 150(12):1327-30. PubMed ID: 25075929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris.
    Sharma VK; Prasad HR; Khandpur S; Kumar A
    Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development?
    Torzecka JD; Woźniak K; Kowalewski C; Waszczykowska E; Sysa-Jedrzejowska A; Pas HH; Narbutt J
    Arch Dermatol Res; 2007 Aug; 299(5-6):239-43. PubMed ID: 17534636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between salivary and serum anti-desmoglein 1 and 3 antibody titres using ELISA and between anti-desmoglein levels and disease severity in pemphigus vulgaris.
    De D; Khullar G; Handa S; Joshi N; Saikia B; Minz RW
    Clin Exp Dermatol; 2017 Aug; 42(6):648-650. PubMed ID: 28543318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab.
    Bhatia SM; Streilein RD; Hall RP
    PLoS One; 2020; 15(6):e0233957. PubMed ID: 32555697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype.
    Harman KE; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2000 Aug; 143(2):343-8. PubMed ID: 10951143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative stress in patients with endemic pemphigus foliaceus and healthy subjects with anti-desmoglein 1 antibodies.
    Gutierrez EL; Ramos W; Seminario-Vidal L; Tello M; Ronceros G; Ortega-Loayza AG
    An Bras Dermatol; 2018 Mar; 93(2):212-215. PubMed ID: 29723379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using desmoglein 1 and 3 enzyme-linked immunosorbent assay as an adjunct diagnostic tool for pemphigus.
    Huang CH; Chen CC; Wang CJ; Chang YT; Liu HN
    J Chin Med Assoc; 2007 Feb; 70(2):65-70. PubMed ID: 17339147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of conventional and conformational anti-desmoglein antibodies with phenotypes and disease activities in patients with pemphigus vulgaris.
    Li Z; Zhang J; Xu H; Jin P; Feng S; Wang B
    Acta Derm Venereol; 2015 Apr; 95(4):462-5. PubMed ID: 25178305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
    España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
    Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases.
    Tampoia M; Zucano A; Villalta D; Antico A; Bizzaro N
    Dermatology; 2012; 225(1):37-44. PubMed ID: 22907099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.